Description

The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.

Related resource: Generic Drug Registration Application (ANDA) in China

6389 results
Export
Log in to view more data,
No. Drug Name Dosage Form Brand Name Strength MAH Note 1 Note 2 Batch
81-21 / ACCORD HEALTHCARE INC / US Orange Book The 81st Batch of Reference Listed Drugs
81-22 / ACCORD HEALTHCARE INC / US Orange Book The 81st Batch of Reference Listed Drugs
81-23 Ontozry Angelini Pharma S.p.A Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs
81-24 ACTONEL THERAMEX IRELAND LIMITED Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs
81-25 ACTONEL THERAMEX IRELAND LIMITED Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs
81-26 Symbicort AstraZeneca AB Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs
81-27 Zyvox Pfizer Limited Original drug not imported to China Approved in UK The 81st Batch of Reference Listed Drugs
81-28 Zevtera Basilea Pharmaceutica Deutschland GmbH UK/ Mercury Pharmaceuticals Ltd Original drug not imported to China Approved in UK The 81st Batch of Reference Listed Drugs
81-29 Rapibloc Amomed Pharma GmbH Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs
81-30 Lipidil 145 ONE Viatris Healthcare GmbH Original drug not imported to China Approved in EU The 81st Batch of Reference Listed Drugs